Resveratrol ameliorates contrast-induced AKI in diabetic nephropathy by activating the SIRT1-PGC-1α-HIF-1α pathway, mitigating hypoxia, mitochondrial dysfunction, and apoptosis (Wang et al., 2019). Here, HIF1A is linked to diabetic kidney disease.